Skip to main content
. 2017 Feb 17;27(3 Suppl):S65–S70. doi: 10.1016/j.je.2016.12.008

Fig. 3.

Fig. 3

Stage-specific distribution of prostate cancer patients in the BioBank Japan project stratified according to prostate-specific antigen levels (<4.0, 4.0–9.0, or ≥10.0 U/mL).